Zicronapine (Lu 31-130) fumarate, an antipsychotic medication, exhibits potent pro-cognitive effects in animal models and holds promise for treating various neurological and psychiatric conditions. It acts as a strong antagonist at dopamine D1/D2 and serotonin 5-HT2A receptors, highlighting its potential therapeutic efficacy [1] [2].